| News

Switzerland Innovation Park Basel Area Site Novartis Campus

30.06.2020

We are happy to present our latest addition to the Switzerland Innovation Park Basel Area: Our site on the Novartis Campus dedicated to digital health provides a focal point to a unique community of digital healthcare experts.

Novartis Campus
Novartis Campus in Basel (img: Mark Niedermann)

In addition to being positioned at the very heart of the Novartis Campus, the site offers fix desks as well as flex desks, a workshop area, an agile workplace and a meeting area. The open space stimulates collaboration.

We particularly invite startups and companies active in the field of digital healthcare and personalized medicine to get in touch with our Community Manager Rahel Schneider to visit our site of the Switzerland Innovation Park Basel Area at the Novartis Campus.

The Switzerland Innovation Park Basel Area maintains four sites, located in Allschwil, Basel and Delémont. The site at the Novartis Campus is the latest addition. In January, the pharmaceutical company communicated the opening of the Campus. Basel Area Business & Innovation with the Switzerland Innovation Park Basel Area is the first external organization to move onto the Campus. The Switzerland Innovation Park Basel Area belongs to the national network of Switzerland Innovation, striving to offer the best place for technology-driven companies to develop their next product and providing easy access to talents, knowledge and expertise.

Share this article

Do you have a question? We'd like to hear from you.

You may also be interested in

Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Yokogawa establishes innovation center in Allschwil

The Japanese conglomerate Yokogawa has established a Swiss subsidiary based at the Switzerland Innovation Park Basel Area. Here, the focus will be on driving forward innovation in the field of biotechnology.

Read More
Basel Area Business & Innovation, Innovation, Invest

Basel gains new biotech in Bright Peak

Versant Ventures has made a US$35 million Series A funding commitment to Bright Peak Therapeutics and has now announced the debut of this biotech. It will operate in Basel and San Diego.

Read More
Basel Area Business & Innovation, Innovation, Switzerland Innovation Park

Robots from Basel set to revolutionize surgery

The Werner Siemens Foundation is to invest an additional 12 million Swiss francs in the Miracle project. Researchers at the University of Basel are developing visionary technology for the use of robots in surgery within the framework of this project.

Read More
Basel Area Business & Innovation, Innovation

T3 Pharma raises over 25 million Swiss francs

T3 Pharmaceuticals AG has closed its third financing round, raising over 25 million Swiss francs. The Basel-based startup has developed a bacterial cancer therapy that it now intends to progress to clinical trials.

Read More
Basel Area Business & Innovation, Innovation

Versameb raises 6 million Swiss francs

The Basel-based biopharmaceutical company Versameb has successfully closed a seed financing round. Versameb develops therapies on the basis of mRNA sequences and is now seeking to drive forward the clinical development of its platform devised for this.

Read More
Basel Area Business & Innovation, Innovation

Genedata accelerating drug development

Genedata, a Basel IT company specializing in the life sciences sector, has agreed a collaboration with Thermo Fisher. The integration of their two platforms will help accelerate the development of drugs.

Read More
1 2 3 32

Do you have a question? We'd like to hear from you.